Potential Carcinogen Prompts Recall Of Nearly 600,000 Bottles Of Blood Pressure Medication

100 Percent Fed Up ^ | November 01, 2025 | Staff

[Red Badger]

The Food and Drug Administration (FDA) said drugmakers have recalled over 580,000 bottles of a blood pressure medication due to concerns it may include a potential carcinogen.

According to CBS News, the agency said that “New Jersey-based drugmaker Teva Pharmaceuticals USA and drug distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of over half a million bottles of various strengths of prazosine capsules.”

The FDA says more than 580,000 bottles of a blood pressure medication have been recalled over concerns that it may contain a cancer-causing chemical. https://t.co/bDF57lel3N— CBS News (@CBSNews) October 31, 2025

CBS News shared more:

The capsule drug, known as prazosin hydrochloride, comes in 1 mg, 2 mg and 5 mg doses. It helps relax blood vessels to facilitate blood flow and is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.

Teva Pharmaceuticals did not immediately respond to a request for comment.

In its recall orders posted on its website, the FDA said it has classified the affected lots of the recalled drug as a Class II risk because some of the medication may have nitrosamine impurities that are considered potentially carcinogenic. The chemicals can form when a drug is manufactured or stored, according to the agency.

“Failed Impurities/Degradation Specification: OOS for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots from the manufacturer,” the FDA said on its recall notice.

NBC 5 Chicago noted:

Oct. 24, the recall was classified as a “Class II,” That means the product “may cause temporary or medically reversible adverse health consequences,” the FDA said, or where the probability of serious adverse health consequences is remote.

According to the Health Hazard Assessment by Teva USA, the overall harm in the patient population is considered to be medium, the California Board of Pharmacy said in a memo.

In a statement sent to NBC Chicago, Teva said those who do take the medication are advised to contact their pharmacy to determine what to do with the remaining quantities, Teva also said it sent recall letters to its customers with instructions for returning recalled product.

Teva went on to say that it had not receive any “relevant complaints” related to the product.

“Prazosin is indicated for the treatment of hypertension, to lower blood pressure, and there are many alternative treatments available to patients,” the statement said. “Teva prioritizes patient safety and product quality at every stage of a medicine’s lifecycle.”

“In addition, consumers with questions or concerns should also contact the health care provider who prescribed the medication,” Teva said.

Read the FDA recall notice HERE.

https://www.accessdata.fda.gov/scripts/ires/?Product=216677

---

TOPICS: Business/Economy; Health/Medicine; Military/Veterans; Society
KEYWORDS:

[Governor Dinwiddie]

So, the choice is between cancer or cerebral aneurysm?

[Red Badger]

“We all gotta die of sumthin’” - Joycelyn Elders................

[barney10]

TEVA is an Indian company and was involved in a large Valsartan recall four years ago. That recall was for the same contamination. This is what happens when the US is dependent on India and China for our generic drugs.

[Reddy]

The article misspelled prazosin.

[exinnj]

TEVA is an Israeli company

[spintreebob]

Another defect in AI (google AI). They look at old, outdated data sources, not recent data sources.

[telescope115]

Wow, that’s not my bp med, thankfully.

[Red Badger]

Valsartan? I used to take that about 6 years ago...............

[mfish13]

Nitrosamines. You have to be exposed over time. Not a one off or short term exposure to potentially get cancer. You would probably be hit by lightning, then get cancer.